Leukemia

Emerging Chemotherapeutic Agents Reported to Drive Growth of Therapy Market

Published in Cancer Weekly, May 23rd, 2000

Decision Resources, Inc., Waltham, Massachusetts, announced the publication of "Acute Leukemias," a multiclient study that assesses a host of market-impacting factors (e.g., epidemiological trends, clinical trial results) to analyze the commercial outlook for drugs in research and development to treat these highly virulent diseases.

While the incidence and prevalence of the acute leukemias are fairly stable in the major pharmaceutical markets under study (United States, France, Germany, Italy, Spain, United Kingdom, and Japan), variations in treatments and the gradual introduction of new analogues continue to drive a slow but steady growth in the sales of drugs to treat...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-05-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry